Biological activity of Morita-Baylis-Hillman adduct homodimers in L. infantum and L. amazonensis: anti-Leishmania activity and cytotoxicity

Parasitology Research
Juliana da Câmara RochaTatjana de Souza Lima Keesen

Abstract

This study is a report on the anti-Leishmania activity of Morita-Baylis-Hillman (MBH) homodimers adducts against the promastigote and axenic amastigote forms of Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis and on the cytotoxicity of these adducts to human blood cells. Both studied homodimers, MBH 1 and MBH 2, showed activity against the promastigote forms of L. infantum and L. amazonensis, which are responsible for visceral and cutaneous leishmaniasis, respectively. Additionally, the homodimers presented biological activity against the axenic amastigote forms of these two Leishmania species. The adducts exhibited no hemolytic activity to human peripheral blood mononuclear cells or erythrocytes at the tested concentrations and achieved higher selectivity indices than amphotericin B. Evaluation of cell death by apoptosis revealed that the homodimers had better apoptosis/necrosis profiles than amphotericin B in the promastigote forms of both L. infantum and L. amazonensis. In conclusion, these Morita-Baylis-Hillman adducts had anti-Leishmania activity in an in vitro model and may thus be promising molecules in the search for new drugs to treat leishmaniasis.

References

Aug 8, 2002·Toxicon : Official Journal of the International Society on Toxinology·L V Costa-LotufoV S N Rao
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Caroline ParisJaqueline Bréard
Mar 24, 2004·International Journal for Parasitology·Alain DebrabantDennis M Dwyer
Oct 11, 2005·Bioorganic & Medicinal Chemistry Letters·P NarenderV Jayathirtha Rao
Dec 14, 2005·Parasitology International·Tânia Ueda-NakamuraCelso Vataru Nakamura
Feb 14, 2006·Pest Management Science·Mário Laa VasconcellosLívia Tc Crespo
Oct 3, 2006·European Journal of Medicinal Chemistry·R O M A de SouzaM L A A Vasconcellos
Aug 24, 2007·FEMS Immunology and Medical Microbiology·Parul TripathiSita Naik
May 2, 2008·European Journal of Medicinal Chemistry·Ticiano P BarbosaMário L A A Vasconcellos
Jun 21, 2011·Bioorganic & Medicinal Chemistry·Ticiano P BarbosaMário L A A Vasconcellos
Jul 25, 2014·International Journal for Parasitology. Drugs and Drug Resistance·Katherine T AndrewsTina S Skinner-Adams
Oct 1, 2014·PloS One·Bruna L Lima MacielSelma Maria Bezerra Jeronimo
Dec 3, 2014·Journal of Ethnopharmacology·Klinger Antonio da Franca RodriguesFernando Aécio de Amorim Carvalho
Mar 5, 2016·PLoS Neglected Tropical Diseases·Mohammad AkhoundiDenis Sereno
Aug 16, 2016·Bioorganic & Medicinal Chemistry Letters·Wagner A V da SilvaMário L A A Vasconcellos
Nov 12, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francisco José Seixas XavierMário Luiz Araújo de Almeida Vasconcellos
Jun 21, 2017·International Journal of Molecular Sciences·Breanna M ScorzaMary E Wilson
Jun 27, 2017·F1000Research·Edoardo Torres-GuerreroRoberto Arenas
Aug 9, 2017·Mediators of Inflammation·Glaucia V Faheina-MartinsDemetrius A M Araújo

❮ Previous
Next ❯

Citations

Sep 17, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Carine S F MarquesPatricia Severino

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry

Software Mentioned

GraphPad
FlowJo
SPSS
TreeStar
GraphPad Prism®

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved